20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • ResearchBible
  • Ulrich's Periodicals Directory
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Recommended Webinars & Conferences
Journal Flyer
Flyer image

Editorial - (2012) Volume 3, Issue 8

IFN-γ-induced Cell Autonomous Immunity to Toxoplasma gondii

Dana G. Mordue*
Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA
*Corresponding Author: Dana G. Mordue, Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA, Tel: 914-594-4981 Email:


Toxoplasma gondii is an obligate intracellular parasite that causes the disease toxoplasmosis. This highly successful parasite is able to infect virtually any warm blooded vertebrate host and host cell even though the definitive host is felidae. Here, we focus on IFN-γ-inducible cell autonomous immunity to T. gondii and mechanisms which the parasite has evolved to evade intracellular antimicrobial defenses. These are discussed in the context of co-evolution of T. gondii with its murine intermediate host.

The obligate intracellular pathogen Toxoplasma gondii is a highly successful parasite that can infect virtually any warm blooded animal even though its sexual cycle is restricted to felidae. Rodents, however, are a significant intermediate host and the parasite has evolved mechanisms to manipulate the behavior of T. gondii infected rodents to increase successful predation by felidae [1-4]. In addition to infecting a wide array of host species, T. gondii also infects virtually any vertebrate host cell as it uses a parasite actin-myosin motor to invade cells circumventing the need for phagocytosis [5,6]. Upon cell invasion, T. gondii forms its own unique intracellular compartment, or Parasitophorous Vacuole (PV), where it replicates, eventually lysing its host cell to egress and invade adjacent cells to resume its lytic cycle. Because T. gondii actively invades host cells forming a nascent PV in the process, it avoids even transient residence in a phagosome [7,8]. Likewise, the PV remains largely segregated from conventional host cell endocytic and exocytic trafficking pathways [9,10].

The relative contribution and efficacy of IFN-γ-inducible antimicrobial effectors varies depending on the intracellular niche occupied by the pathogen, the host species that is infected as well as the pathogen and strain-specific evasion mechanisms. In the case of T. gondii, its unique intracellular niche makes it impervious to antimicrobial mediators that operate strictly within the confines of a phagosome or on free microbes in the cytosol. However, host species have evolved IFN-γ-inducible mechanisms that are capable of acting on T. gondii within its segregated PV [11]. T. gondii has countered this, in part, by evolving a yet undefined mechanism to disrupt chromatin remodeling of STAT1 regulated promoters in infected cells; resulting in suppression of greater than 60% of IFN-γ induced transcripts [12-14]. Consequently, anti-T. gondii effector activity can differ depending on whether host cells are activated prior versus after parasite invasion. However, parasite downregulation of inducible nitric oxide synthase (iNOS) is not necessarily sufficient to avoid growth arrest by the residual nitric oxide (NO) produced even in infected cells and this may hold true for other antimicrobial effectors as well [15]. IFN- γ-inducible indoleamine 2, 3-dioxygenases (IDOs) mediate anti-T. gondii activity by restricting intracellular access to tryptophan; T. gondii is a tryptophan auxotroph [16,17]. IFN-γ-induced gasses such as reactive nitrogen (RNS) and oxygen species (ROS) are ancient and relatively conserved anti-microbial agents that can disrupt function of multiple processes in a microbe simultaneously and have the added benefits of acting synergistically and of being highly diffusible to enable contact with pathogens in diverse intracellular niches. In the case of T. gondii, inducible ROS generated predominantly by NADPH oxidase are capable of anti-T. gondii activity [18-20] during infection in both humans and mice. Similarly, nitric oxide generated by iNOS suppresses parasite replication independent of parasite genotype [21-23]. However, iNOS-/- mice retain the capacity to control acute, but not chronic, T. gondii infection although overall parasite numbers are increased compared to infected wild type mice [24-26]. This may, in part, be a consequence of T. gondii having evolved numerous mechanisms to withstand NO/RNS [27,28]. However, it more likely reflects the dominant and essential role of IFN-γ-induced immunity related p47 GTPases (IRGs) against Type II and III genotypes of the parasite in mice [29-33]. IRGs are sequentially and coordinately recruited (loaded) onto the PV rapidly following parasite invasion and break it down allowing destruction of the parasites within [34,35]. In contrast, the IRG family is largely absent in humans and do not contribute to the human immune response against T. gondii [36]. IFN- γ-inducible p65 Guanylate-Binding Proteins (GBPs) also contribute to anti-T. gondii activity at least in part by aiding the recruitment of IRGs to the PV [37,38]. GBPs unlike IRGs are well represented in humans and could play a role in parasite control in human infections.

Mice are important intermediate hosts for T. gondii and it is possible that the expanded family of IRGs in mice relative to humans may be an evolutionary adaptation to enable chronic versus lethal infection of mice with the parasite. It is evident that T. gondii-genotype-dependent mechanisms have evolved specifically to counter the action of IRGs. Type I genotypes of T. gondii share a phenotype of acute virulence in mice defined as an LD100 of a single parasite [39]. Two secreted parasite rhoptry proteins, ROP18 and ROP5, prevent loading of IRGs to PVs abolishing the effectiveness of IRGs against T. gondii [40-46]. Another parasite genotype-dependent adaptation, ROP16 from Type I and III strains, maintains constitutive activation of STAT 6 (IL-4 pathway) and STAT3 (IL-6 pathway) in macrophages dampening inflammatory cytokine production and possibly skewing infected macrophages to alternative (arginase) versus classical (iNOS) activation and a generally less potent antimicrobial state [47-49]. In contrast, the dense granule protein GRA15 from Type II strain parasites may contribute to classical activation of infected macrophages as it activates NFκB resulting in increased IL-12 production [50]. Rats as well as peritoneal macrophages of rats are naturally more resistant to T. gondii infection compared to mice; a potential consequence of high levels of NO and low levels of arginase and polyamines in rats compared to mice [51]. Therefore, host and parasite-dependent variables impact both the effectiveness of IRGs and the relative ratio of iNOS and arginase in infected macrophages and exert effects on parasite survival.

Overall, it is clear that the potencies of individual antimicrobial effectors against the parasite are dependent on the cell type infected, the activation stimuli, the presence and effectiveness of antimicrobial mediators within different host species and parasite polymorphic differences between genotypes. It is also evident that mice as important intermediate hosts for T. gondii and humans, not only share similarities in their cell autonomous defenses against T. gondii but also have striking and critical differences that must be explored.


  1. Berdoy M, Webster JP, Macdonald DW (2000) Fatal attraction in rats infected with Toxoplasma gondii. Proc Biol Sci 267: 1591-1594.
  2. House PK, Vyas A, Sapolsky R (2011) Predator cat odors activate sexual arousal pathways in brains of Toxoplasma gondii infected rats. PLoS One 6: e23277.
  3. Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, et al. (2011) The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One 6: e23866.
  4. Vyas A, Kim SK, Giacomini N, Boothroyd JC, Sapolsky RM (2007) Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc Natl Acad Sci U S A 104: 6442-6447.
  5. Dobrowolski JM, Sibley LD (1996) Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell 84: 933-939.
  6. Morisaki JH, Heuser JE, Sibley LD (1995) Invasion of Toxoplasma gondii occurs by active penetration of the host cell. J Cell Sci 108: 2457-2464.
  7. Mordue DG, Desai N, Dustin M, Sibley LD (1999) Invasion by Toxoplasma gondii establishes a moving junction that selectively excludes host cell plasma membrane proteins on the basis of their membrane anchoring. J Exp Med 190: 1783-1792.
  8. Mordue DG, Sibley LD (1997) Intracellular fate of vacuoles containing Toxoplasma gondii is determined at the time of formation and depends on the mechanism of entry. J Immunol 159: 4452-4459.
  9. Coppens I, Dunn JD, Romano JD, Pypaert M, Zhang H, et al. (2006) Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space. Cell 125: 261-274.
  10. Mordue DG, Håkansson S, Niesman I, Sibley LD (1999) Toxoplasma gondii resides in a vacuole that avoids fusion with host cell endocytic and exocytic vesicular trafficking pathways. Exp Parasitol 92: 87-99.
  11. MacMicking JD (2012) Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat Rev Immunol 12: 367-382.
  12. Kim SK, Fouts AE, Boothroyd JC (2007) Toxoplasma gondii dysregulates IFN-gamma-inducible gene expression in human fibroblasts: insights from a genome-wide transcriptional profiling. J Immunol 178: 5154-5165.
  13. Lang C, Hildebrandt A, Brand F, Opitz L, Dihazi H, et al. (2012) Impaired chromatin remodelling at STAT1-regulated promoters leads to global unresponsiveness of Toxoplasma gondii-Infected macrophages to IFN-γ. PLoS Pathog 8: e1002483.
  14. Lieberman LA, Banica M, Reiner SL, Hunter CA (2004) STAT1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during toxoplasmosis. J Immunol 172: 457-463.
  15. Lüder CG, Algner M, Lang C, Bleicher N, Gross U (2003) Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages. Int J Parasitol 33: 833-844.
  16. Dai W, Pan H, Kwok O, Dubey JP (1994) Human indoleamine 2,3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells. J Interferon Res 14: 313-317.
  17. Divanovic S, Sawtell NM, Trompette A, Warning JI, Dias A, et al. (2012) Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection. J Infect Dis 205: 152-161.
  18. Aline F, Bout D, Dimier-Poisson I (2002) Dendritic cells as effector cells: gamma interferon activation of murine dendritic cells triggers oxygen-dependent inhibition of Toxoplasma gondii replication. Infect Immun 70: 2368-2374.
  19. Locksley RM, Wilson CB, Klebanoff SJ (1982) Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes. J Clin Invest 69: 1099-1111.
  20. Murray HW, Cohn ZA (1979) Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates. J Exp Med 150: 938-949.
  21. Langermans JA, Van der Hulst ME, Nibbering PH, Hiemstra PS, Fransen L, et al. (1992) IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J Immunol 148: 568-574.
  22. Zhao Y, Ferguson DJ, Wilson DC, Howard JC, Sibley LD, et al. (2009) Virulent Toxoplasma gondii evade immunity-related GTPase-mediated parasite vacuole disruption within primed macrophages. J Immunol 182: 3775-3781.
  23. Zhao Z, Fux B, Goodwin M, Dunay IR, Strong D, et al. (2008) Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens. Cell Host Microbe 4: 458-469.
  24. Khan IA, Matsuura T, Fonseka S, Kasper LH (1996) Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice. J Immunol 156: 636-643.
  25. Khan IA, Schwartzman JD, Matsuura T, Kasper LH (1997) A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc Natl Acad Sci U S A 94: 13955-13960.
  26. Scharton-Kersten TM, Yap G, Magram J, Sher A (1997) Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J Exp Med 185: 1261-1273.
  27. Mordue DG, Scott-Weathers CF, Tobin CM, Knoll LJ (2007) A patatin-like protein protects Toxoplasma gondii from degradation in activated macrophages. Mol Microbiol 63: 482-496.
  28. Skariah S, Bednarczyk RB, McIntyre MK, Taylor GA, Mordue DG (2012) Discovery of a novel Toxoplasma gondii conoid-associated protein important for parasite resistance to reactive nitrogen intermediates. J Immunol 188: 3404-3415.
  29. Butcher BA, Greene RI, Henry SC, Annecharico KL, Weinberg JB, et al. (2005) p47 GTPases regulate Toxoplasma gondii survival in activated macrophages. Infect Immun 73: 3278-3286.
  30. Collazo CM, Yap GS, Hieny S, Caspar P, Feng CG, et al. (2002) The function of gamma interferon-inducible GTP-binding protein IGTP in host resistance to Toxoplasma gondii is Stat1 dependent and requires expression in both hematopoietic and nonhematopoietic cellular compartments. Infect Immun 70: 6933-6939.
  31. Collazo CM, Yap GS, Sempowski GD, Lusby KC, Tessarollo L, et al. (2001) Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection. J Exp Med 194: 181-188.
  32. Henry SC, Daniell XG, Burroughs AR, Indaram M, Howell DN, et al. (2009) Balance of Irgm protein activities determines IFN-gamma-induced host defense. J Leukoc Biol 85: 877-885.
  33. Taylor GA, Collazo CM, Yap GS, Nguyen K, Gregorio TA, et al. (2000) Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A 97: 751-755.
  34. Khaminets A, Hunn JP, Könen-Waisman S, Zhao YO, Preukschat D, et al. (2010) Coordinated loading of IRG resistance GTPases on to the Toxoplasma gondii parasitophorous vacuole. Cell Microbiol 12: 939-961.
  35. Martens S, Parvanova I, Zerrahn J, Griffiths G, Schell G, et al. (2005) Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog 1: e24.
  36. Könen-Waisman S, Howard JC (2007) Cell-autonomous immunity to Toxoplasma gondii in mouse and man. Microbes Infect 9: 1652-1661.
  37. Virreira Winter S, Niedelman W, Jensen KD, Rosowski EE, Julien L, et al. (2011) Determinants of GBP recruitment to Toxoplasma gondii vacuoles and the parasitic factors that control it. PLoS One 6: e24434.
  38. Yamamoto M, Okuyama M, Ma JS, Kimura T, Kamiyama N, et al. (2012) A Cluster of Interferon-γ-Inducible p65 GTPases Plays a Critical Role in Host Defense against Toxoplasma gondii. Immunity 37: 302-313.
  39. Sibley LD, Boothroyd JC (1992) Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 359: 82-85.
  40. Behnke MS, Khan A, Wootton JC, Dubey JP, Tang K, et al. (2011) Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc Natl Acad Sci U S A 108: 9631-9636.
  41. Fleckenstein MC, Reese ML, Könen-Waisman S, Boothroyd JC, Howard JC, et al. (2012) A Toxoplasma gondii pseudokinase inhibits host IRG resistance proteins. PLoS Biol 10: e1001358.
  42. Niedelman W, Gold DA, Rosowski EE, Sprokholt JK, Lim D, et al. (2012) The Rhoptry Proteins ROP18 and ROP5 Mediate Toxoplasma gondii Evasion of the Murine, But Not the Human, Interferon-Gamma Response. PLoS Pathog 8: e1002784.
  43. Reese ML, Zeiner GM, Saeij JP, Boothroyd JC, Boyle JP (2011) Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc Natl Acad Sci U S A 108: 9625-9630.
  44. Saeij JP, Boyle JP, Coller S, Taylor S, Sibley LD, et al. (2006) Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314: 1780-1783.
  45. Steinfeldt T, Könen-Waisman S, Tong L, Pawlowski N, Lamkemeyer T, et al. (2010) Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLoS Biol 8: e1000576.
  46. Taylor S, Barragan A, Su C, Fux B, Fentress SJ, et al. (2006) A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 314: 1776-1780.
  47. Butcher BA, Fox BA, Rommereim LM, Kim SG, Maurer KJ, et al. (2011) Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathog 7: e1002236.
  48. Jensen KD, Wang Y, Wojno ED, Shastri AJ, Hu K, et al. (2011) Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation. Cell Host Microbe 9: 472-483.
  49. Saeij JP, Coller S, Boyle JP, Jerome ME, White MW, et al. (2007) Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 445: 324-327.
  50. Rosowski EE, Lu D, Julien L, Rodda L, Gaiser RA, et al. (2011) Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J Exp Med 208: 195-212.
  51. Li Z, Zhao ZJ, Zhu XQ, Ren QS, Nie FF, et al. (2012) Differences in iNOS and arginase expression and activity in the macrophages of rats are responsible for the resistance against T. gondii infection. PLoS One 7: e35834.
Citation: Mordue DG (2012) IFN-γ-induced Cell Autonomous Immunity to Toxoplasma gondii. J Bacteriol Parasitol 3:e111

Copyright: © 2012 Mordue DG. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.